AUROLLIS Trademark

Trademark Overview

On Thursday, May 22, 2014, a trademark application was filed for AUROLLIS with the United States Patent and Trademark Office. The USPTO has given the AUROLLIS trademark a serial number of 86288773. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 15, 2018. This trademark is owned by Glaxo Group Limited. The AUROLLIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
aurollis

General Information

Serial Number86288773
Word MarkAUROLLIS
Filing DateThursday, May 22, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 15, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 14, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 4, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, January 16, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 15, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2017EXTENSION 5 GRANTED
Tuesday, June 6, 2017EXTENSION 5 FILED
Tuesday, June 13, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 6, 2017TEAS EXTENSION RECEIVED
Tuesday, December 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 10, 2016EXTENSION 4 GRANTED
Thursday, December 1, 2016EXTENSION 4 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Tuesday, July 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 16, 2016EXTENSION 3 GRANTED
Friday, May 27, 2016EXTENSION 3 FILED
Thursday, July 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 27, 2016TEAS EXTENSION RECEIVED
Wednesday, December 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 8, 2015EXTENSION 2 GRANTED
Monday, November 16, 2015EXTENSION 2 FILED
Monday, December 7, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 16, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, May 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 30, 2015EXTENSION 1 GRANTED
Thursday, April 30, 2015EXTENSION 1 FILED
Thursday, April 30, 2015TEAS EXTENSION RECEIVED
Tuesday, December 9, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 14, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 24, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 7, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 2, 2014ASSIGNED TO EXAMINER
Wednesday, June 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 26, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

aurollis pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological